Previous 10 | Next 10 |
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 160 weeks of public selections as part of this ongoing live forward-testing resea...
Over the last three years I have been slowly transitioning my investment focus to what is now almost exclusively fast growing OTC micro caps. I want to capture companies with huge potential in their infancy before they become the next Amazon ( AMZN ), Facebook ( FB ), Google ( GOOG ) (GOOGL), ...
Investing in companies with superior growth rates can produce outstanding returns over the long term. A stock is essentially a share in the ownership of a business, and the price of the stock will follow the value of the business over time. When the business is growing rapidly and ideally ac...
ENGLEWOOD, Colo. , May 18, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics,...
Zynex ( ZYXI ) looks like it may be facing major challenges to its business model, and I have been disturbed by information released by the company over the past few months. Moreover, the stock price (and value multiples) have now reached levels I’d be uncomfortable with in the best of ...
Many investors tend to stay away from stocks that are appreciating strongly over time, mostly because of fears of buying too late when the stock is already overvalued. Having some patience when looking for entry prices and being conscious about valuation is very important. However, blindly avo...
Zynex ( ZYXI ) order growth is slowing down relative to the triple-digit rates in January and February due to the COVID-19 pandemic impact, but it is a temporary setback and these orders are still running at 50%+ levels above last year even with that headwind and the effect on revenue is smoot...
Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI) Q1 2020 Earnings Call Apr 28, 2020 , 4:15 p.m. ET Operator Continue reading
Zynex, Inc. (ZYXI) Q1 2020 Earnings Conference Call April 28, 2020 04:15 PM ET Company Participants Thomas Sandgaard - Founder, Chairman and CEO Dan Moorhead - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Yi Chen - HC Wainwright Marc Wiesenberger - ...
Zynex (NASDAQ: ZYXI ): Q1 GAAP EPS of $0.09 beats by $0.03 . More news on: Zynex, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...